How can you combat the instrument licensing and linguistic validation challenges associated with adopting electronic Clinical Outcome Assessments (eCOA), ensuring quick access to source files?

European regulatory shifts now require the systematic integration of patient data. Success depends on aligning clinical and market access strategies through rigorous evidence generation.

In this webinar, eCOA experts will explore how to implement a BYOD strategy, relevant BYOD regulatory considerations, and where the market is going from here.

Learn the distinctions between a Waiver of Consent and a Waiver of Written Consent in clinical trials, and the importance of informed consent, particularly in the context of virtual trials.

See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.

Discover how digital consent is working to enhance diversity, empower participants with education, drive quality data, and streamline operations.

FDA urges sponsors and CROs to include patient voices in oncology trials. Discover why it matters and how to start integrating this approach.

See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.

With the FDA stating last fall that the “patient’s voice” is key to understanding real-world-impacts, eCOAs and ePROs are becoming quintessential tools for cancer trials.